Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,456 JPY | -3.27% | -1.84% | +28.92% |
04-12 | Daito Pharmaceutical Co.,Ltd. announces an Equity Buyback for 350,000 shares, representing 2.23% for ¥1,000 million. | CI |
04-12 | Daito Pharmaceutical Co.,Ltd. authorizes a Buyback Plan. | CI |
Business Summary
Number of employees: 1,011
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Formulation
57.9
%
| 23,703 | 54.5 % | 26,097 | 57.9 % | +10.10% |
Drug Substance
41.6
%
| 19,481 | 44.8 % | 18,783 | 41.6 % | -3.58% |
Healthy Food
0.5
%
| 279 | 0.6 % | 220 | 0.5 % | -21.15% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 43,464 | 100.0 % | 45,101 | 100.0 % | +3.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kiyotaka Kido
PSD | President | - | - |
Eiichi Takada
CTO | Chief Tech/Sci/R&D Officer | - | - |
Masuo Nomura
ADM | Chief Administrative Officer | - | - |
Director/Board Member | 67 | 23-06-30 | |
Kazushige Hizume
BRD | Director/Board Member | 62 | 85-03-31 |
Junichi Kikuta
BRD | Director/Board Member | 74 | 10-02-28 |
Michio Tsuda
BRD | Director/Board Member | 76 | 71-03-31 |
Yasunobu Otsuga
BRD | Director/Board Member | 73 | 75-02-28 |
Radomir Gibala
PRN | Corporate Officer/Principal | - | 12-31 |
Masahiro Harai
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Yasunobu Otsuga
BRD | Director/Board Member | 73 | 75-02-28 |
Michio Tsuda
BRD | Director/Board Member | 76 | 71-03-31 |
Hitoshi Hori
BRD | Director/Board Member | 70 | 99-01-31 |
Junichi Kikuta
BRD | Director/Board Member | 74 | 10-02-28 |
Kiyotaka Kido
PSD | President | - | - |
Kazumi Yamamoto
BRD | Director/Board Member | 67 | 12-07-31 |
Atsushi Saino
BRD | Director/Board Member | 50 | 16-07-31 |
Kazushige Hizume
BRD | Director/Board Member | 62 | 85-03-31 |
Director/Board Member | 67 | 23-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 15,698,440 | 12,400,506 ( 78.99 %) | 55,050 ( 0.3507 %) | 78.99 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
DAIICHI SANKYO CO., LTD. 0.01% | 163,500 | 0.01% | 5,573,120 $ |
80,400 | 0.00% | 2,549,972 $ | |
61,100 | 0.00% | 1,612,482 $ | |
80,000 | 0.02% | 1,157,055 $ | |
181,037 | 0.28% | 1,072,199 $ | |
41,500 | 0.09% | 903,235 $ | |
19,200 | 0.04% | 717,659 $ | |
RIKEN VITAMIN CO., LTD. 0.12% | 39,200 | 0.12% | 677,808 $ |
30,300 | 0.06% | 546,253 $ | |
35,905 | 0.03% | 442,296 $ |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.92% | 251M | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B |
- Stock Market
- Equities
- 4577 Stock
- Company Daito Pharmaceutical Co.,Ltd.